Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  206.14
+0.87 (0.42%)
AAPL  274.01
+7.83 (2.94%)
AMD  210.04
+13.44 (6.84%)
BAC  50.05
-1.02 (-1.99%)
GOOG  309.33
-2.36 (-0.76%)
META  634.82
-2.43 (-0.38%)
MSFT  386.83
+2.36 (0.61%)
NVDA  190.35
-1.20 (-0.63%)
ORCL  145.64
+4.33 (3.06%)
TSLA  403.31
+3.48 (0.87%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.